pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation

BACKGROUND: RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated nanostructured lipid carriers (RIPL-NLCs) can facilitate selective drug delivery to hepsin (Hpn)-expressing cancer cells, but they exhibit low stability in the blood. Generally, biocompatible and nontoxic poly(ethylene glycol) surface modificati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Nanomedicine
Autors principals: Kim, Chang Hyun, Sa, Cheol-Ki, Goh, Min Su, Lee, Eun Seok, Kang, Tae Hoon, Yoon, Ho Yub, Battogtokh, Gantumur, Ko, Young Tag, Choi, Young Wook
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6204877/
https://ncbi.nlm.nih.gov/pubmed/30425481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S184355
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars